HTR-8/SVneo cells - also known as HTR-8/SV neo, HTR-8/SV-neo, HTR8/SVneo, and HTR8svn - are a widely used human trophoblast cell line established by Graham et al. in 1993 [1]. The line was created by introducing the simian virus 40 large T antigen into first-trimester human trophoblasts, granting the cells an extended lifespan far beyond the 12–14 passages typical of the parental HTR-8 line. Since their establishment, HTR-8/SVneo cells have become an indispensable in vitro model for studying placental trophoblast biology, including cell invasion, migration, and proliferation. Researchers worldwide rely on this line to investigate pregnancy disorders such as preeclampsia, gestational diabetes mellitus, and recurrent spontaneous abortion, as well as to explore the effects of environmental toxicants and pharmacological agents on trophoblast function.

Key Takeaways

• HTR-8/SVneo is a SV40-immortalised human trophoblast line derived from first-trimester placental tissue (Cellosaurus accession: CVCL_7162).
• The line contains a mixed population of epithelial trophoblast-like and mesenchymal/stromal-like cells, making it a model for epithelial-to-mesenchymal transition (EMT) studies [2].
• HTR-8/SVneo cells are extensively used to study preeclampsia, gestational diabetes mellitus, recurrent spontaneous abortion, and intrahepatic cholestasis of pregnancy.
• The line exhibits a near-triploid karyotype with intra-clonal variability, a characteristic common to long-term cultured trophoblastic cell lines [3].
• HTR-8/SVneo cells are part of the ENCODE project common cell types (tier 3) and have available DNA methylation omics data.
• Dozens of derived knockout and reporter lines have been generated, reflecting the broad utility of this parental cell line in functional genomics.

What is HTR-8/SVneo?

HTR-8/SVneo was established from first-trimester human placental trophoblasts obtained from a donor of unspecified sex at a gestational age of 6–12 weeks. No associated maternal disease was recorded for the donor. The cells were immortalised by transfection with the simian virus 40 large T antigen gene, yielding a transformed cell line (CVCL_7162) with indefinite proliferative capacity [1]. Both the parental HTR-8 line and the resulting HTR-8/SVneo line were confirmed to be cytokeratin-positive, affirming their epithelial trophoblastic identity. The transfected line uniquely secretes human chorionic gonadotrophin, a characteristic not observed in the parental cells.

Subsequent characterisation revealed that HTR-8/SVneo is not a homogeneous trophoblast population. Abou-Kheir and colleagues demonstrated that the line contains two distinct cell populations: one with epithelial trophoblast characteristics and another with mesenchymal or stromal features [2]. This mixed population has implications for interpreting experimental results, particularly in invasion and migration assays. Cytogenomic analysis further showed that HTR-8/SVneo carries a near-triploid karyotype with inter- and intra-clonal chromosomal aberrations arising from prolonged culture [3]. Molecular profiling confirmed that HTR-8/SVneo shares several, but not all, markers characteristic of primary extravillous trophoblast subpopulations [4].

HTR-8/SVneo — Culture Information

HTR-8/SVneo – Low confluency

HTR-8/SVneo – High Confluency

Advantages of HTR-8/SVneo Cells

HTR-8/SVneo cells offer several compelling advantages for placental and reproductive research. The SV40 immortalisation grants the line a stable, extended lifespan, far surpassing the 12–14 passages achievable with the parental HTR-8 cells [1]. This longevity enables large-scale, reproducible experiments without the logistical challenges of sourcing fresh primary trophoblasts. The cells retain key trophoblastic markers — including cytokeratin expression and human chorionic gonadotrophin secretion — providing a biologically relevant context for mechanistic studies of placental function.

The line's responsiveness to a broad range of experimental manipulations makes it particularly versatile. Researchers have successfully applied RNA interference, plasmid overexpression, CRISPR-Cas9 knockout, and pharmacological treatments to HTR-8/SVneo cells across diverse research questions [5] [6]. The cells respond predictably to hypoxic conditions, high-glucose environments, and cytokine stimulation, faithfully recapitulating aspects of pathological states including preeclampsia and gestational diabetes mellitus [7] [8]. Furthermore, a growing panel of derived knockout lines enables targeted functional genomics without the need to re-engineer the parental line from scratch.

Limitations of HTR-8/SVneo Cells

The most significant limitation of HTR-8/SVneo is its mixed cell population. Characterisation studies confirmed the coexistence of epithelial trophoblast-like and mesenchymal stromal-like cells within the same culture [2]. This heterogeneity complicates the attribution of experimental observations to a single, defined cell type. Results obtained using bulk populations may obscure subpopulation-specific responses, and care must be taken when extrapolating findings to pure primary trophoblast behaviour.

The near-triploid and aneuploid karyotype of HTR-8/SVneo represents a further caveat [3]. Chromosomal instability, which may increase with passage number, can alter gene dosage and consequently influence signalling pathway outputs. Additionally, while HTR-8/SVneo cells share multiple molecular markers with primary extravillous trophoblasts, they do not fully recapitulate all features of any single primary trophoblast subpopulation [4]. Investigators should therefore complement HTR-8/SVneo data with primary cell validation or in vivo models wherever possible, particularly for studies involving differentiation or endocrine function.

Applications of HTR-8/SVneo Cells

Preeclampsia Research

Preeclampsia (PE) is one of the most intensively studied pregnancy disorders using HTR-8/SVneo cells. The cell line serves as a tractable in vitro model for hypoxia-induced trophoblast dysfunction, a central feature of PE pathogenesis. Fan and colleagues used HTR-8/SVneo cells cultured under hypoxic conditions to demonstrate that oestrogen receptor α (ERα) transcriptionally activates ACSL4, promoting ferroptosis — a form of iron-dependent cell death — in placental trophoblasts [9]. Silencing ERα attenuated oxidative stress markers and restored cell viability, identifying a novel therapeutic axis.

Epigenetic and transcriptional mechanisms in PE have also been elucidated with this model. Zhao and colleagues showed that SETD7-mediated H3K4me3 modification on the LncRNA XIST promoter drives trophoblast pyroptosis through a FOXA1/TMBIM4/GSDMD-N axis in hypoxia-reoxygenation-treated HTR-8/SVneo cells [7]. Separately, Zhu and colleagues found that PTPRN2 — upregulated in hypoxic HTR-8/SVneo cells — suppresses trophoblast invasion by inhibiting the Wnt/β-catenin pathway, linking aberrant tyrosine phosphatase signalling to shallow placentation in PE [10]. Wang and colleagues further demonstrated that the transcription factor IRF1 regulates PANoptosis in hypoxic HTR-8/SVneo cells via HDAC1, offering insight into the multi-modal cell death pathways operating in PE [11].

CCN5 (WISP-2) has emerged as another regulator of trophoblast behaviour in PE. Gong and colleagues reported that CCN5 overexpression in HTR-8/SVneo cells significantly suppressed proliferation, migration, invasion, and epithelial-mesenchymal transition, while CCN5 knockdown had the opposite effects [12]. Cheng and colleagues additionally showed that TGFβ1 restricts HTR-8/SVneo cell migration, invasion, and proliferation through a tissue transglutaminase-mediated activation of the TLR4/NF-κB pathway, providing a mechanistic link between placental fibrosis and trophoblast dysfunction in PE [13].

Gestational Diabetes and Trophoblast Dysfunction

Gestational diabetes mellitus (GDM) creates a hyperglycaemic placental microenvironment that impairs trophoblast function. HTR-8/SVneo cells treated with high glucose concentrations replicate key aspects of GDM-associated trophoblast injury. Lin and colleagues employed this model to investigate placental ferroptosis in GDM, analysing ultrastructure, reactive oxygen species generation, and iron accumulation. They found that metformin attenuated ferroptosis markers in both HTR-8/SVneo cells and placental samples from GDM patients, suggesting a protective mechanism for this antidiabetic drug [14].

Zhang and colleagues identified neurotrophin-4 (NTF4) as a GDM-associated factor upregulated in placental tissue from affected patients. In high-glucose-challenged HTR-8/SVneo cells, NTF4 silencing reduced apoptosis and inflammatory cytokine secretion while restoring proliferative capacity. These effects were mediated through the PI3K/AKT signalling pathway, implicating NTF4 as a potential therapeutic target in GDM-related placental dysfunction [8]. Additionally, Yu and colleagues showed that serum miR-320a is elevated in GDM patients and directly targets a key regulatory gene in HTR-8/SVneo cells, suppressing proliferation and promoting apoptosis. This microRNA also held predictive value for fetal macrosomia, connecting trophoblast-level molecular changes to adverse neonatal outcomes [15].

Recurrent Spontaneous Abortion and Pregnancy Loss

HTR-8/SVneo cells are a valuable tool for studying recurrent spontaneous abortion (RSA) and related trophoblast dysfunction. Huang and colleagues induced ferroptosis in HTR-8/SVneo cells using erastin to model RSA-associated trophoblast injury. They found that the traditional Chinese medicine formulation Anzi Tiaochong Tang inhibited ferroptosis through the METTL14/m6A/SLC39A14 axis, reducing iron accumulation and oxidative stress. This study demonstrated how m6A RNA methylation coordinates iron metabolism in trophoblasts and identified a potential therapeutic strategy for RSA [16].

The role of N6-methyladenosine (m6A) epitranscriptomic reprogramming in trophoblast viability was further explored by Ye and Deng, who showed that METTL14 promotes trophoblast dysfunction by enhancing SZRD1 expression in an m6A-dependent manner in HTR-8/SVneo cells. Elevated SZRD1 impaired proliferation, migration, invasion, and angiogenesis, mirroring the shallow trophoblast invasion characteristic of preeclampsia and early pregnancy loss [17]. These studies collectively highlight HTR-8/SVneo cells as a productive platform for dissecting epitranscriptomic regulation in reproductive pathology.

Trophoblast invasion is also regulated by microRNAs active during early placentation. Arora and colleagues used HTR-8/SVneo cells to show that miR-22-3p targets Sp1, thereby reducing cystathionine β-synthase expression and diminishing MMP-2 and MMP-9 activity. This cascade restricts trophoblast invasive capacity and may contribute to placentation defects underlying early-onset preeclampsia and other adverse outcomes [18].

Environmental Toxicology and Reproductive Safety

HTR-8/SVneo cells have proven highly suitable for evaluating the reproductive toxicity of environmental contaminants and pharmacological agents. Zhang and colleagues investigated the tyre antioxidant 6PPD, demonstrating that high-dose exposure induced cellular senescence in HTR-8/SVneo cells by suppressing BAZ1B-mediated ubiquitination and degradation of p21. This senescence programme compromised trophoblast function and was associated with unexplained miscarriage in a clinical case-control study, establishing a mechanistic link between tyre-derived pollution and pregnancy loss [19].

Pharmacological safety concerns were addressed by Liu and colleagues, who used HTR-8/SVneo cells to uncover the mechanism of triptolide-induced reproductive toxicity. Integrated MeRIP-seq and mRNA-seq revealed that triptolide — the active component of Tripterygium wilfordii — extensively reprogrammed the m6A epitranscriptome, altering expression of over 1,700 genes and inducing trophoblast cell injury [6]. Hu and colleagues additionally showed that glutathione depletion in HTR-8/SVneo cells elevates reactive oxygen species, causes DNA damage, and activates the cGAS-STING inflammatory pathway — a mechanism relevant to oxidative placental injury from environmental exposures [5].

Studies in the context of pregnancy-related liver disease further demonstrate the versatility of HTR-8/SVneo cells. Xu and colleagues used the line alongside spatial metabolomics to investigate how bile acid accumulation in intrahepatic cholestasis of pregnancy (ICP) drives trophoblast apoptosis through glycerophospholipid metabolic reprogramming [20]. Liu and colleagues separately validated the protective effects of the traditional Chinese medicine Yinzhihuang oral liquid in taurocholic acid-induced HTR-8/SVneo cells, demonstrating its capacity to restore trophoblast viability under cholestatic conditions [21].

Conclusion

HTR-8/SVneo cells remain one of the most productive and widely deployed human trophoblast models in reproductive biology. From elucidating the mechanisms of preeclampsia, gestational diabetes mellitus, and spontaneous abortion to assessing the reproductive hazards of environmental pollutants and pharmacological agents, the cell line has demonstrated remarkable utility across diverse research contexts. Its responsiveness to hypoxia, hyperglycaemia, and epigenetic manipulation — combined with the availability of a growing panel of derived knockout lines — ensures that HTR-8/SVneo cells will continue to generate fundamental insights into placental physiology and pathology. Researchers seeking a well-characterised, biologically relevant trophoblast model will find HTR-8/SVneo cells an indispensable tool. To purchase HTR-8/SVneo cells or make an enquiry, visit cytion.com.

Key Publications

1. Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N, Lala PK (1993) Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Experimental cell research. PMID: 7684692
2. Abou-Kheir W, Barrak J, Hadadeh O, Daoud G (2017) HTR-8/SVneo cell line contains a mixed population of cells. Placenta. PMID: 28161053
3. Weber M, Weise A, Vasheghani F (2021) Cytogenomics of six human trophoblastic cell lines. Placenta. PMID: 33096371
4. Pastuschek J, Nonn O, Gutiérrez-Samudio RN (2021) Molecular characteristics of established trophoblast-derived cell lines. Placenta. PMID: 33810901
5. Hu S, Liu W, Dong Y (2026) Glutathione depletion activates cGAS-STING signaling via oxidative stress in preeclampsia. Molecular immunology. PMID: 42068604
6. Liu X, Wu Y, Tian J (2026) Reprogramming of the m(6)A Epitranscriptome Drives Triptolide-Induced Reproductive Toxicity in HTR-8/SVneo Cells. Toxics. PMID: 42043161
7. Zhao X, Li L, Wang Y (2026) SETD7-mediated epigenetic regulation of LncRNA XIST promotes trophoblast pyroptosis: a study in preeclampsia mouse and cell models. Biology direct. PMID: 42177518
8. Zhang L, Yang J (2026) Inhibition of NTF4 Attenuates High Glucose-Induced Apoptosis and Inflammation in HTR-8/SVneo Cells via the PI3K/AKT Pathway. Immunity, inflammation and disease. PMID: 42036822
9. Fan X, Yang Y, Zhu X (2026) ERα Facilitates Hypoxia-induced Ferroptosis in Placental Trophoblasts by Transcriptionally Activating ACSL4. American journal of reproductive immunology. PMID: 42160036
10. Zhu T, Zeng WJ, Zhang Y (2026) Hypoxia-Induced PTPRN2 Suppresses Trophoblast Invasion via Wnt/β-Catenin Pathway Inhibition. Current medical science. PMID: 42154150
11. Wang Z, Cheng L, Li G (2026) Transcription factor IRF1 modulates HDAC1 and PANoptosis to regulate preeclampsia progression. Biology direct. PMID: 42035194
12. Gong Y, Li J, Wang C (2026) CCN5 overexpression suppresses trophoblast HTR-8/SVneo cell proliferation, migration, invasion, and epithelial-mesenchymal transition. European journal of pharmacology. PMID: 42178008
13. Cheng M, Di X, Chen Q (2026) TGFβ1 Inhibits Migration, Invasion, and Proliferation of HTR-8/Svneo Cells via tTG-Activated TLR4/NF-κB Signaling Pathway. Journal of biochemical and molecular toxicology. PMID: 42008735
14. Lin Q, Qin X, Shen M (2026) Metformin and Placental Ferroptosis in Gestational Diabetes: A Mechanistic Study. Journal of diabetes research. PMID: 42237524
15. Yu R, Liu X, Zhang S (2026) Identification of serum miR‑320a in gestational diabetes mellitus for predicting macrosomia and in vitro mechanistic investigation. BMC medical genomics. PMID: 42210203
16. Huang S, Yu M, Luo Y (2026) Anzi Tiaochong Tang inhibits trophoblast ferroptosis via the METTL14/m6A/SLC39A14 axis in recurrent spontaneous abortion. Frontiers in pharmacology. PMID: 42137328
17. Ye Q, Deng L (2026) METTL14 promotes trophoblast dysfunction by elevating SZRD1 expression in an m6A-dependent manner. Human cell. PMID: 42133253
18. Arora P, Kalra S, Dhingra R (2025) MicroRNA-22 (miR-22) Regulates Trophoblast Cell Invasion via the Specificity Protein 1 (Sp1)/Cystathionine β-Synthase (CBS)/Matrix Metalloproteinases 2 and 9 (MMP-2 and MMP-9) Pathway. Cureus. PMID: 41583211
19. Zhang W, Liang Y, Sun Y (2026) Exposure to high doses of tyre antioxidant 6PPD causes senescence to induce unexplained miscarriage by suppressing BAZ1B-mediated ubiquitination degradation of P21. EBioMedicine. PMID: 42224779
20. Xu ZT, Ge LX, Luo L (2026) PIP(2) Accumulation in the Spongiotrophoblast Drives Trophoblast Apoptosis in Intrahepatic Cholestasis of Pregnancy. Molecular reproduction and development. PMID: 42017405
21. Liu T, Zhuang X, Gu W (2025) Yinzhihuang Oral Liquid Alleviates Intrahepatic Cholestasis of Pregnancy: Integrated Bioinformatics and Experimental Mechanistic Insight. Maternal-fetal medicine. PMID: 41608209